Creutzfeldt-Jakob Disease

🧠 Standard of Care & Symptoms

Creutzfeldt-Jakob Disease (CJD) is a rare, rapidly progressive, universally fatal neurodegenerative disorder belonging to the family of transmissible spongiform encephalopathies (TSEs).

• Presentation: Key clinical features.
  • *Rapidly Progressive Dementia:* Extremely rapid deterioration of memory, judgment, orientation, and executive function. Unlike typical dementias that develop over years, CJD cognitive decline progresses over weeks or months.
  • *Myoclonus:* Involuntary, brief, shock-like muscle twitches. It is classically triggered or exaggerated by sudden sensory stimuli such as loud noises or touch (**startle myoclonus**).
  • *Cerebellar Ataxia:* Uncoordinated movements, clumsiness, waddling gait, and tremors, caused by early degeneration of the cerebellum.
  • *Pyramidal & Extrapyramidal Signs:* Muscle rigidity, bradykinesia (slow movements), spasticity, and hyperreflexia.
  • *Akinetic Mutism:* In the terminal phase, patients lose the ability to speak, swallow, or move, entering a state of complete immobility.

🧬 Diagnostics & Prion Pathophysiology

Diagnosis relies on cerebrospinal fluid (CSF) assays, EEG findings, and specific brain MRI abnormalities. Definitive diagnosis requires neuropathological examination of brain tissue.

• Diagnostic Markers: Key criteria.
  • RT-QuIC (CSF): Real-Time Quaking-Induced Conversion is the gold-standard diagnostic test. It detects minute quantities of misfolded prion protein in CSF with >95% sensitivity and >98% specificity.
  • 14-3-3 & Tau Proteins (CSF): High levels of 14-3-3 and total tau proteins serve as markers for rapid neuronal destruction.
  • Brain MRI: DWI and FLAIR sequences show hyperintensity in the caudate nucleus and putamen, or in the cerebral cortex in a ribbon-like pattern (**cortical ribboning**).
  • Electroencephalography (EEG): Classically reveals periodic sharp wave complexes (PSWCs) in the middle-to-late stages of the disease.

Pathophysiology of Prion Misfolding

The rapid brain tissue destruction in CJD is driven by the infectious template-directed misfolding of prion proteins:

• PrP^C to PrP^Sc Conversion: The pathology is initiated by the conformational change of the normal, predominantly alpha-helical cellular prion protein (**PrP^C**) into the abnormal, beta-sheet-rich, protease-resistant scrapie isoform (**PrP^Sc**).
• Template-Induced Misfolding: PrP^Sc binds to normal PrP^C, acting as a template to catalyze its conversion into the misfolded PrP^Sc conformation. This self-propagating cascade leads to the accumulation of insoluble, protease-resistant prion aggregates.
• Spongiform Encephalopathy: The accumulation of PrP^Sc aggregates triggers vacuolation (formation of microscopic fluid-filled holes) in the gray matter of the brain, leading to widespread neuronal loss, synaptic dysfunction, and reactive astrogliosis (spongiform change).

💊 Symptom Management & Palliative Care

There is no disease-modifying therapy or cure for CJD. The standard of care focuses entirely on palliative care to manage symptoms and maximize patient comfort.

Symptom Management

• Myoclonus Control: Benzodiazepines, specifically **Clonazepam** (0.5 mg to 2.0 mg daily), or antiepileptics like **Sodium Valproate** or Levetiracetam, are used to suppress distressing muscle jerks.
• Psychiatric Symptoms: Neuroleptics or atypical antipsychotics (e.g., Quetiapine) may be used to manage severe agitation, hallucinations, or anxiety.

Palliative & Support Care

• Hospice Enrollment: Because the median survival from symptom onset is only **4 to 6 months**, immediate enrollment in a comprehensive hospice or palliative care program is strongly recommended upon diagnosis.
• Supportive Care: Feeding assistance, positioning to prevent pressure ulcers, and aggressive pain management. Genetic counseling is indicated for families with familial CJD (caused by mutations in the *PRNP* gene).

🔬 Active Clinical Trials

Clinical trials are currently evaluating anti-PrP monoclonal antibodies, antisense oligonucleotides to knock down PrP^C expression, and small molecules preventing misfolding.

🗺️ Next Steps After Diagnosis

If a family member has recently been diagnosed with Creutzfeldt-Jakob Disease, establish these clinical care pathways:

1. Confirm RT-QuIC and MRI Findings: Review CSF RT-QuIC and brain MRI (cortical ribboning) with a neurologist specializing in cognitive disorders.
2. Engage Palliative/Hospice Services Immediately: Establish care with a local hospice provider to coordinate comfort care and home support.
3. Prescribe Myoclonus Suppressants: Discuss Clonazepam or Sodium Valproate with the neurologist if involuntary twitching becomes frequent or distressing.
4. Consider PRNP Genetic Testing: Discuss genetic counseling if there is a family history of rapidly progressive dementia to evaluate the *PRNP* gene for familial CJD.

❓ Patient FAQ

Q: What are the differences between sporadic, familial, and variant CJD?
A: **Sporadic CJD** accounts for 85% of cases and occurs spontaneously for no known reason. **Familial CJD** accounts for 10-15% of cases and is caused by an inherited mutation in the *PRNP* gene. **Variant CJD** (vCJD) is a rare form linked to eating meat contaminated with Bovine Spongiform Encephalopathy (BSE, "mad cow disease"), which has a younger age of onset, slower progression, and distinct psychiatric initial symptoms.

Q: Can CJD be transmitted through casual contact?
A: No. CJD cannot be transmitted through casual contact, kissing, touching, or breathing the same air. Transmission has only occurred iatrogenically through direct exposure to contaminated brain tissue or corneas during neurosurgery, or via contaminated human growth hormone injections before modern screening protocols.